Alcoholic hepatitis medical therapy
|
Alcoholic hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alcoholic hepatitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Alcoholic hepatitis medical therapy |
|
Risk calculators and risk factors for Alcoholic hepatitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Medical Therapy
Corticosteroids
Clinical practice guidelines by the American College of Gastroenterology recommend corticosteroids.[1]
Patients with a discriminant function score > 32 or hepatic encephalopathy should be considered for treatment with prednisolone 40 mg daily for four weeks followed by a taper.[1]
Pentoxifylline
A randomized controlled trial found that 5 patients with a discriminant function score > 32 and at least one of palpable tender hepatomegaly, fever, leukocytosis, hepatic encephalopathy, or hepatic systolic bruit must be treated with pentoxifylline 400 mg orally 3 times daily for 4 weeks for one to prevent one patient from dying. [2]
Acute Pharmacotherapies
- In very severe disease, such as those with encephalopathy or other markers of advanced disease, treatment with steroids may improved outcome – Prednisolone 40 mg every day for 4 weeks and then tapered.
- Possible contraindications to steroids must be considered, such as acute infection, gastrointestinal (GI) hemorrhage, etc.
- Other considerations:
- Acetaminophen use should be < 2gm / day
- Fasting also increases risks of acetaminophen toxicity in alcoholics
- Propylthiouracil (PTU) has been tried in these patients and may be moderately effective in patients who continue the treatment and discontinue alcohol.
- Colchicine 0.6 mg by mouth, twice daily may help to slow progression of liver disease, though the data is not conclusive.
References
- ↑ 1.0 1.1 McCullough AJ, O'Connor JF (1998). "Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology". Am. J. Gastroenterol. 93 (11): 2022–36. PMID 9820369.
- ↑ Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000). "Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial". Gastroenterology. 119 (6): 1637–48. doi:10.1053/gast.2000.20189. PMID 11113085. (ACP Journal Club synopsis)